C1 Inhibitor (Human) (Haegarda) and Paclitaxel Intravenous
Determining the interaction of C1 Inhibitor (Human) (Haegarda) and Paclitaxel Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: paclitaxel
Brand name: Onxol, Taxol
Synonyms: Paclitaxel, PACLitaxel (Conventional)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 Inhibitor (Human) (Haegarda)-Paclitaxel Novaplus
- C1 Inhibitor (Human) (Haegarda)-Paclitaxel protein-bound
- C1 Inhibitor (Human) (Haegarda)-Paclitaxel protein-bound Intravenous
- C1 Inhibitor (Human) (Haegarda)-Pacnex
- C1 Inhibitor (Human) (Haegarda)-Pacnex LP
- C1 Inhibitor (Human) (Haegarda)-Pacnex MX
- Paclitaxel Intravenous-C1 Inhibitor (Recombinant)
- Paclitaxel Intravenous-C1-Esterase Inhibitor (Human)
- Paclitaxel Intravenous-C1-Esterase Inhibitor (Recombinant)
- Paclitaxel Intravenous-Cabazitaxel
- Paclitaxel Intravenous-Cabazitaxel Intravenous
- Paclitaxel Intravenous-Cabergoline